共 40 条
- [1] Koyama A(1997)Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases Am J Kidney Dis 29 526-532
- [2] Igarashi M(1999)Corticosteroids in IgA nephropathy: a randomised controlled trial Lancet 353 883-887
- [3] Kobayashi M(2001)Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy Am J Kidney Dis 38 736-743
- [4] Pozzi C(2007)Remission of proteinuria improves prognosis in IgA nephropathy J Am Soc Nephrol 18 3177-3183
- [5] Bolasco PG(2010)Predictors for progression in immunoglobulin A nephropathy with significant proteinuria Nephrology 15 236-241
- [6] Fogazzi GB(2012)Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy Clin Exp Nephrol 16 883-891
- [7] Hotta O(2008)Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study Hypertens Res 31 433-441
- [8] Miyazaki M(2003)Proteinuria and the risk of developing end-stage renal disease Kidney Int 63 1468-1474
- [9] Furuta T(2004)Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial J Am Soc Nephrol 15 157-163
- [10] Reich HN(2006)Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study Am J Kidney Dis 47 751-760